Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Avanos Medical (AVNS) Interest Expenses (2016 - 2025)

Avanos Medical (AVNS) has disclosed Interest Expenses for 13 consecutive years, with $1.9 million as the latest value for Q4 2025.

  • Quarterly Interest Expenses fell 32.14% to $1.9 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $7.8 million through Dec 2025, down 36.07% year-over-year, with the annual reading at $7.8 million for FY2025, 36.07% down from the prior year.
  • Interest Expenses hit $1.9 million in Q4 2025 for Avanos Medical, up from $1.8 million in the prior quarter.
  • In the past five years, Interest Expenses ranged from a high of $4.7 million in Q3 2023 to a low of $700000.0 in Q4 2021.
  • Historically, Interest Expenses has averaged $2.4 million across 5 years, with a median of $2.8 million in 2022.
  • Biggest five-year swings in Interest Expenses: crashed 81.4% in 2021 and later surged 328.57% in 2022.
  • Year by year, Interest Expenses stood at $700000.0 in 2021, then soared by 328.57% to $3.0 million in 2022, then rose by 10.0% to $3.3 million in 2023, then decreased by 15.15% to $2.8 million in 2024, then crashed by 32.14% to $1.9 million in 2025.
  • Business Quant data shows Interest Expenses for AVNS at $1.9 million in Q4 2025, $1.8 million in Q3 2025, and $2.0 million in Q2 2025.